Medtronic stock down 5% as surgical unit offsets ablation and diabetes growth
Medtronic posted a strong profit for Q3 of fiscal year 2025, though shares were down as its cardiac ablation product …
Post
-
-
UK research team to initiate study into Digostics at-home diabetes test
The UK’s National Institute for Health & Care Research (NIHR) Oxford Biomedical Research Centre is set to initiate a study …
-
Enlitic and GE HealthCare to team up on medical imaging migration
Enlitic and its subsidiary Laitek have announced a strategic partnership with GE HealthCare to transform AI-driven enterprise imaging solutions migration. The …
-
Navi lands FDA clearance for vascular access placement system
The US Food and Drug Administration (FDA) has granted 510(k) clearance to the Neonav electrocardiogram (ECG) tip location system, a …
-
FDA grants 510(k) clearance to Targeted Genomics’ GlutenID test
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Targeted Genomics’ GlutenID test, designed to screen for …
-
Harper Health collaborates with OpenDNA to offer monogenic screening
Primary care provider Harper Health has collaborated with genetic health solutions provider OpenDNA to offer patients access to polygenic and …
-
GenAI clinical conversation startup Abridge scoops $250m
Abridge has closed a $250m Series D funding raise for its AI-powered medical note platform, highlighting how investment into the …
-
Boston Scientific bags CE marking for Farapulse catheter and software
Boston Scientific has gained a duo of CE markings in the European Union (EU) for its navigation enabled Farawave NAV …
-
BD recalls ChloraPrep applicators lot over fungal contamination
BD has announced a voluntary worldwide recall of a single lot of ChloraPrep Clear 1mL applicators over contamination under specific …
-
EDX Medical develops new ‘super test’ for prostate cancer
EDX Medical has developed a new non-invasive prostate cancer test it hopes will transform diagnosis and detection of the disease. The …
-
Johnson & Johnson to resume market release of Varipulse catheter in US
Johnson & Johnson is set to resume the limited market release of the Varipulse Catheter, a treatment option for atrial …
-
University of Hong Kong develops AI imaging tool for faster cancer diagnosis
A team from the University of Hong Kong (HKU) has developed an AI-driven imaging tool, Cyto-Morphology Adversarial Distillation (CytoMAD), which …
-
AI-driven virtual care revolutionises patient safety and hospital efficiency
Vitalacy's AI-powered Virtual Care system is revolutionising patient monitoring by minimising fall risks and easing caregiver workload pressures, according to …
-
Bio-Rad set to acquire Stilla Technologies
Bio-Rad has entered a binding offer to purchase all equity interests in French biotech Stilla Technologies. According to Bio-Rad, Stilla, which …
-
WhiteSwell’s eLym System trial indicates positive outcomes for ADHF patients
WhiteSwell has reported encouraging results from its DELTA-HF trial, which evaluated the minimally invasive catheter-based eLym System in treating individuals …
